We are live on
!
Find out more
Harvard Bioscience
HBIO
HBIO
79 hedge funds and large institutions have $82.4M invested in Harvard Bioscience in 2013 Q2 according to their latest regulatory filings, with 79 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
2,620% more call options, than puts
Call options by funds: $136K | Put options by funds: $5K
Holders
79
Holders Change
+79
Holders Change %
–
% of All Funds
2.58%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
79
Increased
–
Reduced
–
Closed
–
Calls
$136K
Puts
$5K
Net Calls
+$131K
Net Calls Change
+$131K
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DADC
76
D.A. Davidson & Co
Great Falls,
Montana
| $4K | +$4.56K | +119 | New |
|
77
Schroder Investment Management Group
London,
United Kingdom
| $3.76K | +$4.06K | +106 | New |
|
|
U
78
UBS
Zurich,
Switzerland
| $3K | +$3.52K | +92 | New |
|
|
LTFS
79
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | +$1.53K | +40 | New |
|
HBIO Hedge Fund Activity: Q2 2013 in Review
79 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Harvard Bioscience (HBIO) for Q2 2013, worth a combined $82.4M.
Buyers outnumbered sellers: 79 funds opened new HBIO positions and 0 closed out — a net gain of 79 holders — while 0 added to existing stakes and 0 trimmed.
- 79 institutional investors held Harvard Bioscience (HBIO) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $82.4M of Harvard Bioscience stock for Q2 2013.
- 79 funds opened new Harvard Bioscience positions in Q2 2013 and 0 closed out, a net change of +79 holders.
Based on aggregated 13F filings for Q2 2013.